Aerosol emission from the respiratory tract does not appear to be increased by HFNO. Although direct comparisons are complex, cough appears to be the main aerosol-generating risk out of all measured ...

We thank Jeffrey Wagner for his comments on our real-world investigation of respiratory syncytial virus (RSV) vaccine effectiveness among adults aged 60 years and older in the USA.1 In response to his ...

Keywords: respiratory tract infection, COVID-19, respiratory syncytial virus, hospital admission, health care use, immunity debt Citation: Methi F and Magnusson K (2025) The accuracy of forecasted ...

Persistent wildfire smoke from Canadian wildfires has shrouded Minnesota in haze, significantly reducing visibility and triggering statewide air quality alerts.

Objectives Prescribing antibiotics may reinforce patients’ beliefs that antibiotics are needed and increase future consultations for similar symptoms. This review determines the effect of antibiotic ...

WEDNESDAY, July 30, 2025 (HealthDay News) -- Nirsevimab is effective for protecting infants against respiratory syncytial virus (RSV)-associated lower respiratory tract disease (LRTD), according ...

Nirsevimab is effective for protecting infants against respiratory syncytial virus (RSV)-associated lower respiratory tract disease (LRTD), according to a study published online July 22 in Pediatrics.